SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (170)5/31/2001 3:23:26 AM
From: nigel bates  Read Replies (1) of 1022
 
I take it this is why you are asking ?
The Company recently announced the issuance of a sixth patent in its antibody expression family of patents that broadly covers methods for secreting antibodies from bacteria. Bacterial antibody expression is a key enabling technology for the discovery and selection as well as development and manufacture, of many recombinant antibody-based pharmaceuticals. The Company has licensed its expression technology to over 20 companies worldwide. In the first quarter XOMA concluded such licenses with Alexion Pharmaceuticals Inc., a biopharmaceutical company and Syrrx, Inc., a structural proteomics and drug discovery company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News